Why is the US opioid crisis described as a "man-made" crisis, and what makes it a case for medical ethics?
Because a manufacturer's aggressive, misleading marketing of the painkiller OxyContin played down addiction risks and pushed doctors to prescribe opioids far more widely, and the company then blamed patients for "irresponsible use". It shows commercial interests overriding non-maleficence in medicine.
Purdue Pharma's marketing (portrayed in the series Dopesick) was "aggressive, excessive and inappropriate", under-communicated risks and "very much exacerbated" abuse. The tactics:
- patient discounts on prescription opioids (a foot-in-the-door technique),
- direct-to-consumer advertising promising pain-free living ("There Can Be Life with Relief") to normalise opioid use,
- encouraging doctors to "overcome their opiophobia" and prescribe for a wider range of conditions,
- sponsoring thousands of pain-related education events for doctors and nurses,
- political influence where regulation was weak, including in low- and middle-income countries.
Then, in response to the crisis, the company and its owners blamed consumers for "irresponsible use".
The ethical lessons: non-maleficence was undermined at the source, before any doctor saw a patient; the trust patients place in prescriptions (an information asymmetry) was exploited; and blaming users shifts responsibility from a system designed to sell onto the people harmed by it, much like the self-inflicted-illness argument in rationing.
Go deeper:
McDonald et al. (2023): Pills and the damage done: the opioid epidemic as man-made crisis — the open-access paper behind this analysis.- Wikipedia: Opioid epidemic in the United States — the waves of the crisis and their causes.
Dopesick: official trailer — the series dramatising the case.